RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting five posters at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The Conference will take place September 12-15, 2010 at the Boston Convention and Exhibition Center in Boston, MA.
